{"entity":{"id":"nct05821686","kind":"trial","name":"Efficacy of Interleukin-2 in Triple Negative Breast Cancer","aka":[],"tldr":"A phase 1/2 trial in triple-negative breast cancer, run by Nova Scotia Health Authority, not yet recruiting.","summary":"Efficacy of Interleukin-2 in Triple Negative Breast Cancer is a phase 1/2, interventional study registered as NCT05821686 by Nova Scotia Health Authority, with a registry enrolment figure of 10 participants, started 2026-01-02 and due to reach its primary completion in 2028-04. Interventions recorded: Human Interleukin-2 (IL-2) (Proleukin). Conditions listed: Triple Negative Breast Cancer. Triple-negative eligibility wording from the registry: \"Women with biopsy proven TNBC who are not scheduled to receive neoadjuvant chemotherapy\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05821686","url":"https://clinicaltrials.gov/study/NCT05821686"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05821686","phase":"1/2","setting":"Efficacy of Intralesional IL-2 for Resectable Triple Negative Breast Cancer","sponsor":"Nova Scotia Health Authority","participation":[{"nct":"NCT05821686","source":"https://clinicaltrials.gov/study/NCT05821686","fetchedAt":"2026-10-07T16:53:56.649Z","studySha256":"8368f20ce5c346d6f65e652b2108577697750d1e2e7af2ea94714d0eadfe4324","overallStatus":"NOT_YET_RECRUITING","lastUpdatePosted":"2025-02-12","leadSponsor":"Nova Scotia Health Authority","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"80 Years","sex":"FEMALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":10,"enrolmentType":"ESTIMATED","siteCount":0,"recruitingSiteCount":0}],"started":"2026-01-02","startedType":"estimated","enrolled":10,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05821686/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}